Cardiometabolic Mortality and Health System Expansion in Kuwait (2010-2022): A National Time-Series Analysis
1Department of Public Health Practice, College of Public Health, Kuwait University, Sabah Al-Salem University City, Al-Shadadiya, Safat, Kuwait City 13110, Kuwait.
Journal of Clinical Medicine
|April 14, 2026
Summary
Cardiometabolic disease deaths, particularly from diabetes, rose in Kuwait despite health system growth. Strengthening prevention and metabolic risk control is crucial for sustainable non-communicable disease policy.
Area of Science:
- Public Health
- Epidemiology
- Health Services Research
Background:
- Cardiometabolic diseases are a major global cause of early death.
- Longitudinal mortality patterns in Gulf Cooperation Council (GCC) settings are not well understood.
- This study analyzes cardiometabolic mortality trends in Kuwait (2010-2022) alongside health system metrics.
Purpose of the Study:
- To characterize national trends in cardiometabolic mortality in Kuwait.
- To examine the relationship between mortality trends and health system financing, capacity, and utilization.
- To identify specific drivers of cardiometabolic mortality, including diabetes and ischaemic heart disease.
Main Methods:
- Ecological time-series analysis of Ministry of Health administrative data (2010-2022).
- Inclusion of mortality, cardiac care unit (CCU) capacity and discharges, cardiovascular procedures, and expenditure.
- Ordinary least squares regression used to estimate annual trends, with pre-COVID models (2010-2019) to differentiate effects.
Main Results:
- All-cause deaths increased significantly (5448 in 2010 to 8041 in 2022).
- Diabetes mortality (counts and rates) showed significant progressive increases, becoming a prominent driver.
- Ischaemic heart disease death counts rose, while hypertensive mortality declined; health system capacity (MOH expenditure, CCU metrics) expanded significantly.
Conclusions:
- Kuwait experienced rising cardiometabolic mortality, notably from diabetes, concurrent with substantial health system expansion.
- Tertiary care capacity growth alone is insufficient to counteract underlying epidemiological pressures.
- Urgent focus on upstream prevention, diabetes surveillance, and metabolic risk management is vital for sustainable non-communicable disease policy.
Related Concept Videos
Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Drug Dosing: Obese Patients
353
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
353
Introduction To Survival Analysis
930
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
930
Kaplan-Meier Approach
775
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
775
Cancer Survival Analysis
855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Assessment of the Cardiovascular System I: Subjective Data
997
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
997


